IRS1 and fatty liver disease: For example, insulin resistance has been shown to promote hepatic steatosis via insulin receptor substrate-1 (IRS1) activation of sterol regulatory element-binding protein-1c (SREBP1c), the major regulator of hepatic fatty acid synthesis [51,55].